Leisure time in economic evaluation: Theoretical and practical considerations

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 4, Issue 1, 2004, Pages 1-3

  Sendi, Pedram ^a   Brouwer, Werner B F ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC ASPECT; ECONOMIC EVALUATION; EDITORIAL; HEALTH STATUS; HUMAN; INCOME; LEISURE; MANUAL LABOR; MEASUREMENT; MEDICAL RESEARCH; OUTCOMES RESEARCH; PHYSICAL ACTIVITY; PRODUCTIVITY; QUALITY OF LIFE; RELIABILITY; RESOURCE MANAGEMENT; SATISFACTION; SOCIAL ASPECT; WORKING TIME;

EID: 1142311632     PISSN: 14737167     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737167.4.1.1     Document Type: Editorial

References (15)

1. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. Oxford University Press, Oxford, UK (1996).
2. Brouwer W, Rutten F, Koopmanschap M. Costing in economic evaluations. In: Economic Evaluation in Healthcare: Merging Theory With Practice. Drummond MF, McGuire A (Eds). Oxford University Press, Oxford, UK, 68-93 (2001).
3. Brouwer WB, Koopmanschap MA, Rutten FF. Patient and informal caregiver time in cost-effectiveness analysis. A response to the recommendations of the Washington Panel. Int. J. Technol. Assess.Healthcare 14, 505-513 (1998).
4. Meltzer D, Johannesson M. Inconsistencies in the 'societal perspective' on costs of the panel on Cost-Effectiveness in Health and Medicine. Med. Dec. Making 19, 371-377 (1999).
5. Brouwer WB, Koopmanschap MA, Rutten FF. Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion. Health Econ. 6, 511-514 (1997).
6. Brouwer WB, Koopmanschap MA, Rutten FF. Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel. Health Econ. 6, 253-259 (1997).
7. Weinstein MC, Siegel JE, Garber AM et al. Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group. Health Econ. 6, 505-510 (1997).
8. Sculpher M. The role and estimation of productivity costs in economic evaluation. In: Economic Evaluation In Healthcare: Merging Theory With Practice. Drummond MF, McGuire A (Eds). Oxford University Press, Oxford, UK 94-112 (2001).
9. Ehrenberg RG, Smith RS. Modern Labor Economics: Theory and Public Policy. Eighth Edition. Addison-Wesley Series in Economics, MA, USA (2003).
10. O'Brien B, Gafni A. When do the 'dollars' make sense? Toward a conceptual framework for contingent valuation studies in healthcare. Med. Dec. Making 16, 288-299 (1996).
11. Shaw WD. Searching for the opportunity cost of an individuals time. Land Economics 68, 107-115 (1992).
12. Johannesson M. Avoiding double-counting in pharmacoeconomic studies. PharmacoEconomics 11, 385-388 (1997).
13. Brooks R. EuroQol: the current state of play. Health Pol. 37, 53-72 (1996).
14. Brouwer WB, Rutten FF. The missing link: on the line between C and E. Health Econ. 12, 629-636 (2003).
15. Sendi P, Brouwer WB. Do people consider the effects of ill-health on income and leisure when answering health-related quality-of-life questions? Value Health 6, 767 (2003).